Phibro Animal Health Corporation(PAHC)

Research Snapshot

Phibro Animal Health Corporation (PAHC) is a Healthcare stock with a market cap of $2.22B and listed on NASDAQ. The stock last traded around $31.50 and up 22.2% across the available one-year price window (Jun 27, 2025 → Jun 24, 2026). Baseline metrics include revenue growth of +27.4%, EPS growth of +1883.3%, a dividend yield of 0.9%. What stands out right now is revenue +27.4%, EPS +1883.3%, free cash flow -9.8% with operating margin 11.6% and ROIC 10.7%. The dividend is present but secondary, with a yield around 0.9%. Valuation is more restrained than many high-expectation growth names at P/E 24.2 and price/sales 1.5. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines PAHC price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.